1. Home
  2. ABCL vs PAHC Comparison

ABCL vs PAHC Comparison

Compare ABCL & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABCL
  • PAHC
  • Stock Information
  • Founded
  • ABCL 2012
  • PAHC 1946
  • Country
  • ABCL Canada
  • PAHC United States
  • Employees
  • ABCL N/A
  • PAHC N/A
  • Industry
  • ABCL Biotechnology: Pharmaceutical Preparations
  • PAHC Biotechnology: Pharmaceutical Preparations
  • Sector
  • ABCL Health Care
  • PAHC Health Care
  • Exchange
  • ABCL Nasdaq
  • PAHC Nasdaq
  • Market Cap
  • ABCL 719.0M
  • PAHC 682.5M
  • IPO Year
  • ABCL 2020
  • PAHC 2014
  • Fundamental
  • Price
  • ABCL $2.65
  • PAHC $24.46
  • Analyst Decision
  • ABCL Buy
  • PAHC Sell
  • Analyst Count
  • ABCL 3
  • PAHC 3
  • Target Price
  • ABCL $8.50
  • PAHC $19.00
  • AVG Volume (30 Days)
  • ABCL 2.6M
  • PAHC 174.8K
  • Earning Date
  • ABCL 11-04-2024
  • PAHC 11-06-2024
  • Dividend Yield
  • ABCL N/A
  • PAHC 1.96%
  • EPS Growth
  • ABCL N/A
  • PAHC N/A
  • EPS
  • ABCL N/A
  • PAHC 0.43
  • Revenue
  • ABCL $32,962,000.00
  • PAHC $1,046,762,000.00
  • Revenue This Year
  • ABCL N/A
  • PAHC $21.75
  • Revenue Next Year
  • ABCL $38.78
  • PAHC $12.67
  • P/E Ratio
  • ABCL N/A
  • PAHC $56.92
  • Revenue Growth
  • ABCL N/A
  • PAHC 7.17
  • 52 Week Low
  • ABCL $2.34
  • PAHC $9.49
  • 52 Week High
  • ABCL $6.06
  • PAHC $25.98
  • Technical
  • Relative Strength Index (RSI)
  • ABCL 45.91
  • PAHC 56.80
  • Support Level
  • ABCL $2.62
  • PAHC $24.23
  • Resistance Level
  • ABCL $3.18
  • PAHC $25.98
  • Average True Range (ATR)
  • ABCL 0.18
  • PAHC 0.90
  • MACD
  • ABCL -0.01
  • PAHC 0.08
  • Stochastic Oscillator
  • ABCL 22.06
  • PAHC 60.21

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company have extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

About PAHC Phibro Animal Health Corporation

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

Share on Social Networks: